IFNG and cancer: In this experimental system, we observed that the REIC/Dkk-3-treated MDA-MB-231 cells activate NK cells, as indicated by the increase in IFN-γ (Fig. 7a), and are more fragile to NK cells than the control BSA-treated cancer cells (Fig. 7b).